MedPath

Phase I study of preoperative chemo-radiotherapy with alternate-day administrations of S-1 and radiation in patients with pancreatic cancer

Phase 1
Conditions
pancreatic cancer
Registration Number
JPRN-UMIN000003795
Lead Sponsor
Wakayama Medical University, School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
12
Inclusion Criteria

Not provided

Exclusion Criteria

1)Active double cancer 2)Severe diarrhea 3)Symptomatic pulmonary fibrosis or interstitial pneumonia. Marked pleural or peritoneal effusion 4)Metastasis in central nervous system 5)para-aortic lymph node metastasis 6)Severe complications, such as ileus, heart failure and renal failure 7)Pregnant females, possibly pregnant females, females wishing to become pregnant and nursing mothers. Males that are currently attempting to produce a pregnancy 8)History of severe anaphylaxies 9)Active infection 10)Severe mental disorder 11)Patients under treatment with flucytosine, phenytoin or warfarin potassium 12)Inadequate physical condition, as diagnosed by primary physician

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Safety,Efficacy
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath